Magnitude of Non-alcoholic Fatty Liver Disease in South East Asia Region

Main Article Content

Aayushi Rastogi
Umesh Kapil

Abstract

Background: Non-alcoholic Fatty Liver Disease (NAFLD) is a recognised public health problem in the developed world. The prevalence of NAFLDis escalating in developing countries along with increased prevalence of metabolic syndrome. Limited medical literature on NAFLD is contributed by American and European countries which may not be generalizable to Asians. Hence, it is important to study the Asian experience, particularly South-East Asian region (SEAR) with respect to NAFLD for better understanding.


Methods: All published articles in the MEDLINE database on NAFLD in South-East Asia were included. The important findings were summarized and critically analysed.


Results: Prevalence of NAFLD in the SEAR region ranges from 8.0% to 77.0%. NAFLD in South east Asia was associated with metabolic syndrome particularly obesity and insulin resistance. ‘Lean NAFLD’ is a novel concept that describes NAFLD among non-obese individuals.


Conclusion: NAFLD is an emerging problem in South-east Asia. This review summarizes the prevalence of NAFLD in SEAR region and discusses the implications of these findings. Further population-based studies on prevalence and incidence are required on obese and lean NAFLD to quantify the magnitude of the disease in SEAR for better management of the condition.

Downloads

Download data is not yet available.

Article Details

How to Cite
Rastogi, A., & Kapil, U. (2020). Magnitude of Non-alcoholic Fatty Liver Disease in South East Asia Region. Journal of Health Science and Alternative Medicine, 2(1), 1-11. Retrieved from https://he01.tci-thaijo.org/index.php/jhealthscialternmed/article/view/241249
Section
Special Articles

References

[1] Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328–57.
[2] Non-alcoholic Fatty Liver Disease and Metabolic Syndrome—Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology - Journal of Clinical and Experimental Hepatology [Internet]. [cited 2020 Apr 9]. Available from: https://www.jcehepatology.com/article/S0973-6883(15)00035-3/fulltext
[3] EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Journal of Hepatology. 2016 Jun;64(6):1388–402.
[4] McPherson S, Hardy T, Henderson E, Burt AD, Day CP, Anstee QM. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. J Hepatol. 2015 May;62(5):1148–55.
[5] Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2015 Apr;13(4):643-654.e1-9; quiz e39-40.
[6] Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, et al. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2015 Aug;149(2):389-397.e10.
[7] Loomba R, Schork N, Chen C-H, Bettencourt R, Bhatt A, Ang B, et al. Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study. Gastroenterology. 2015 Dec;149(7):1784–93.
[8] Schwimmer JB, Celedon MA, Lavine JE, Salem R, Campbell N, Schork NJ, et al. Heritability of nonalcoholic fatty liver disease. Gastroenterology. 2009 May;136(5):1585–92.
[9] Cui J, Chen C-H, Lo M-T, Schork N, Bettencourt R, Gonzalez MP, et al. Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study. Hepatology. 2016;64(5):1547–58.
[10] Genes or Environment to Determine Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease - PubMed [Internet]. [cited 2020 Mar 29]. Available from: https://pubmed.ncbi.nlm.nih.gov/17032401/
[11] Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention | Nature Reviews Gastroenterology & Hepatology [Internet]. [cited 2020 Apr 9]. Available from: https://www.nature.com/articles/nrgastro.2017.109
[12] Petersen KF, Dufour S, Feng J, Befroy D, Dziura J, Man CD, et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18273–7.
[13] Liu C-J. Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese. J Gastroenterol Hepatol. 2012 Oct;27(10):1555–60.
[14] Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84.
[15] Zelber-Sagi S, Lotan R, Shlomai A, Webb M, Harrari G, Buch A, et al. Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up. J Hepatol. 2012 May;56(5):1145–51.
[16] Whalley S, Puvanachandra P, Desai A, Kennedy H. Hepatology outpatient service provision in secondary care: a study of liver disease incidence and resource costs. Clin Med (Lond). 2007 Apr;7(2):119–24.
[17] Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology. 2019 May 1;4(5):389–98.
[18] Li Z, Xue J, Chen P, Chen L, Yan S, Liu L. Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies. J Gastroenterol Hepatol. 2014 Jan;29(1):42–51.
[19] Saokaew S, Kanchanasuwan S, Apisarnthanarak P, Charoensak A, Charatcharoenwitthaya P, Phisalprapa P, et al. Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score). Liver Int. 2017;37(10):1535–43.
[20] Cahyono SB, Bayupurnama P, Ratnasari N, Maduseno S, Nurdjanah S. Ultrasound-Diagnosed Non-Alcoholic Fatty Liver Disease among Medical Check Up Patients. 2013;14(3):5.
[21] Khan MMR, Rahman MK, Sana NK, Basak PM, Sarker BC, Islam MA, et al. Nonalcoholic Fatty Liver Disease and Metabolic Syndrome among patients attending in a tertiary care center in Bangladesh. TAJ: Journal of Teachers Association. 2015;28(2):44–51.
[22] Su1037 Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease in a Rural Community of South Asia - Gastroenterology [Internet]. [cited 2020 Apr 10]. Available from: https://www.gastrojournal.org/article/S0016-5085(15)33567-8/abstract
[23] Alam S, Fahim SM, Chowdhury MAB, Hassan MdZ, Azam G, Mustafa G, et al. Prevalence and risk factors of non‐alcoholic fatty liver disease in Bangladesh. JGH Open. 2018 Mar 30;2(2):39–46.
[24] Full article: High prevalence of non-alcoholic fatty liver disease (NAFLD) among Gujarati Indians in North London: a population-based study [Internet]. [cited 2020 Apr 10]. Available from: https://www.tandfonline.com/doi/full/10.1080/17584299.2017.1326709
[25] Alam S, Chowdhury MAB, Azam G, Ahsan M, Mustafa MdG, Hossain M, et al. Prevalence of fatty liver in Bangladesh: A nation wide population based study. In 2017.
[26] Saha M, Nahar K, Parveen I, Mahmuduzzaman M, Hosen MA, Mutsuddy P, et al. Sonographically Detected Non Alcoholic Fatty Liver Disease in Apparently Healthy Adults and Associated Factors. Mymensingh Med J. 2017;26(1):109–16.
[27] Wangdi K, Jamtsho T. Risk factors for self-reported diabetes among Bhutanese adults: A nationally representative survey data analysis. PLOS ONE. 2018 Nov 15;13(11):e0206034.
[28] Bhatta MP, Assad L, Shakya S. Socio-Demographic and Dietary Factors Associated with Excess Body Weight and Abdominal Obesity among Resettled Bhutanese Refugee Women in Northeast Ohio, United States. Int J Environ Res Public Health. 2014 Jul;11(7):6639–52.
[29] Lee K. Relationship between uric acid and hepatic steatosis among Koreans. Diabetes Metab. 2009 Dec;35(6):447–51.
[30] Amarapurkar D, Kamani P, Patel N, Gupte P, Kumar P, Agal S, et al. Prevalence of non-alcoholic fatty liver disease: population based study. Ann Hepatol. 2007 Sep;6(3):161–3.
[31] Mohan V, Farooq S, Deepa M, Ravikumar R, Pitchumoni CS. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res Clin Pract. 2009 Apr;84(1):84–91.
[32] Das K, Das K, Mukherjee PS, Ghosh A, Ghosh S, Mridha AR, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology. 2010;51(5):1593–602.
[33] Majumdar A, Misra P, Sharma S, Kant S, Krishnan A, Pandav CS. Prevalence of nonalcoholic fatty liver disease in an adult population in a rural community of Haryana, India. Indian J Public Health. 2016 Mar;60(1):26–33.
[34] Singh SP, Nayak S, Swain M, Rout N, Mallik RN, Agrawal O, et al. Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey. Trop Gastroenterol. 2004 Jun;25(2):76–9.
[35] Anurag L, Aniket S, Shalik J, Amarja L, Dhananjay R, Sachin J. Non-alcoholic fatty liver disease prevalence and associated risk factors--A study from rural sector of Maharashtra. Trop Gastroenterol. 2015 Mar;36(1):25–30.
[36] High prevalence of non‐alcoholic fatty liver disease among healthy male blood donors of urban India - Duseja - 2019 - JGH Open - Wiley Online Library [Internet]. [cited 2020 Apr 12]. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/jgh3.12117
[37] Misra A, Misra R, Wijesuriya M, Banerjee D. The metabolic syndrome in South Asians: continuing escalation & possible solutions. Indian J Med Res. 2007 Mar;125(3):345–54.
[38] Misra A, Vikram NK. Insulin resistance syndrome (metabolic syndrome) and Asian Indians. Current Science. 2002;83(12):1483–96.
[39] pubmeddev, S MS and A. The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: a study from South India. - PubMed - NCBI [Internet]. [cited 2020 Apr 12]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/22672067
[40] Bhatt SP, Guleria R, Vikram NK, Gupta AK. Non-alcoholic fatty liver disease is an independent risk factor for inflammation in obstructive sleep apnea syndrome in obese Asian Indians. Sleep Breath. 2019 Mar 1;23(1):171–8.
[41] Ajmal MR, Yaccha M, Malik MA, Rabbani MU, Ahmad I, Isalm N, et al. Prevalence of nonalcoholic fatty liver disease (NAFLD) in patients of cardiovascular diseases and its association with hs-CRP and TNF-α. Indian Heart J. 2014 Dec;66(6):574–9.
[42] Bajaj S, Nigam P, Luthra A, Pandey RM, Kondal D, Bhatt SP, et al. A case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease. Indian J Med Res. 2009 Mar;129(3):285–92.
[43] Nigam P, Bhatt SP, Misra A, Vaidya M, Dasgupta J, Chadha DS. Non-Alcoholic Fatty Liver Disease Is Closely Associated with Sub-Clinical Inflammation: A Case-Control Study on Asian Indians in North India. PLoS One [Internet]. 2013 Jan 11 [cited 2020 Apr 12];8(1). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543427/
[44] Parry IA, Bhat RA, Khan I. The Prevalence of Non-alcoholic Fatty Liver Disease and its Association with Metabolic Syndrome and Obesity in Pediatric Population of North India [Internet]. 2013 [cited 2020 Apr 12]. Available from: https://www.semanticscholar.org/paper/The-Prevalence-of-Non-alcoholic-Fatty-Liver-Disease-Parry-Bhat/e359ce72cc8417778da118a54c335496b576ec2b
[45] Anderson EL, Howe LD, Jones HE, Higgins JPT, Lawlor DA, Fraser A. The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis. PLoS One [Internet]. 2015 Oct 29 [cited 2020 Mar 29];10(10). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626023/
[46] Goyal P, Thapa B, Sharma NR, Menon J, Bhatia A. Nutritional assessment in obese children with and without non-alcoholic fatty liver disease (NAFLD) in an Urban Area of Punjab, India. Ind Jour of Publ Health Rese & Develop. 2018;9(12):201.
[47] Chaturvedi K, Vohra P. Non-alcoholic fatty liver disease in children. Indian Pediatr. 2012 Sep;49(9):757–8.
[48] Pawar SV, Zanwar VG, Choksey AS, Mohite AR, Jain SS, Surude RG, et al. Most overweight and obese Indian children have nonalcoholic fatty liver disease. Ann Hepatol. 2016 Dec;15(6):853–61.
[49] Das MK, Sibal A, Bhatia V, Sahu S, Arora NK. Nonalcoholic Fatty Liver Disease in North Indian Children and Association With Metabolic Syndrome: Are Normal-Weight Children Spared? Clinical Gastroenterology and Hepatology. 2014 Jan 1;12(1):163–4.
[50] WHO | Disease burden and mortality estimates [Internet]. WHO. World Health Organization; [cited 2020 Apr 12]. Available from: https://www.who.int/healthinfo/global_burden_disease/estimates/en/
[51] Hazim A, Purnamasari D, Kalista KF, Lesmana CRA, Nugroho P. The influence of insulin resistance in the occurence of non-alcoholic fatty liver disease among first degree relatives of type 2 diabetes. Diabetes Metab Syndr. 2019 Apr;13(2):1431–5.
[52] Zhou B, Lu Y, Hajifathalian K, Bentham J, Cesare MD, Danaei G, et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. The Lancet. 2016 Apr 9;387(10027):1513–30.
[53] Abarca-Gómez L, Abdeen ZA, Hamid ZA, Abu-Rmeileh NM, Acosta-Cazares B, Acuin C, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. The Lancet. 2017 Dec 16;390(10113):2627–42.
[54] Nakai K, Win KM, Oo SS, Arakawa Y, Abe K. Molecular Characteristic-Based Epidemiology of Hepatitis B, C, and E Viruses and GB Virus C/Hepatitis G Virus in Myanmar. J Clin Microbiol. 2001 Apr;39(4):1536–9.
[55] Mittal A, Sathian B, Chandrasekharan N, Lekhi A, Farooqui SM, Pandey N. Diagnostic Accuracy of Serological Markers in Viral Hepatitis and Non Alcoholic Fatty Liver Disease. A Comparative Study in Tertiary Care Hospital of Western Nepal. Nepal Journal of Epidemiology. 2011;1(2):60–3.
[56] Wang Z, Xu M, Hu Z, Shrestha UK. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index. Menopause. 2015 Jun;22(6):667–73.
[57] Paudel MS, Tiwari A, Mandal A, Shrestha B, Kafle P, Chaulagai B, et al. Metabolic Syndrome in Patients with Non-alcoholic Fatty Liver Disease: A Community Based Cross-sectional study. Cureus [Internet]. [cited 2020 Apr 10];11(2). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476620/
[58] Niriella MA, Kasturiratna A, Beddage T, Ediriweera DS, De Silva ST, Perera KR, et al. Non-resolution of non-alcoholic fatty liver disease (NAFLD) among urban, adult Sri Lankans in the general population: A prospective, cohort follow-up study. PLoS One [Internet]. 2019 Oct 29 [cited 2020 Apr 11];14(10). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818953/
[59] Kasturiratne A, Akiyama K, Niriella MA, Takeuchi F, Isono M, Dassanayake AS, et al. Association of genetic variants with non-alcoholic fatty liver disease in an urban Sri Lankan community. Liver Int. 2015 Feb;35(2):676–9.
[60] Niriella MA, Pathmeswaran A, De Silva ST, Kasturiratna A, Perera R, Subasinghe CE, et al. Incidence and risk factors for non-alcoholic fatty liver disease: A 7-year follow-up study among urban, adult Sri Lankans. Liver Int. 2017;37(11):1715–22.
61. Herath HMM, Kodikara I, Weerarathna TP, Liyanage G. Prevalence and associations of non-alcoholic fatty liver disease (NAFLD) in Sri Lankan patients with type 2 diabetes: A single center study. Diabetes Metab Syndr. 2019 Feb;13(1):246–50.
[62] Silva H, Siriwardana RC, Niriella MA, Dassanayake AS, Liayange CAH, Gunathilake B, et al. Nonalcoholic fatty liver disease among potential live liver donors--a preliminary experience from Sri Lanka. Indian J Gastroenterol. 2014 Nov;33(6):573–4.
[63] Herath RP, Siriwardana SR, Ekanayake CD, Abeysekara V, Kodithuwakku SUA, Herath HP. Non-alcoholic fatty liver disease and pregnancy complications among Sri Lankan women: A cross sectional analytical study. PLoS ONE. 2019;14(4):e0215326.
[64] Perera N, Indrakumar J, Abeysinghe WV, Fernando V, Samaraweera WMCK, Lawrence JS. Non alcoholic fatty liver disease increases the mortality from acute coronary syndrome: an observational study from Sri Lanka. BMC Cardiovasc Disord [Internet]. 2016 Feb 12 [cited 2020 Apr 11];16. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751701/
[65] Bulathsinhala BKS, Siriwardana RC, Gunetilleke MB, Niriella MA, Dassanayake A. Clinical characteristics and outcomes of hepatocellular carcinoma: results from prospective study, from a tertiary referral center in 
Sri Lanka. Ceylon Med J. 2018 Sep 30;63(3):133–8.
[66] Pinidiyapathirage MJ, Dassanayake AS, Rajindrajith S, Kalubowila U, Kato N, Wickremasinghe AR, et al. Non-alcoholic fatty liver disease in a rural, physically active, low income population in Sri Lanka. BMC Res Notes. 2011 Nov 24;4:513.
[67] Rajindrajith S, Pathmeswaran A, Jayasinghe C, Kottahachchi D, Kasturiratne A, de Silva ST, et al. Non-alcoholic fatty liver disease and its associations among adolescents in an urban, Sri Lankan community. BMC Gastroenterol. 2017 Nov 29;17(1):135.
[68] Tantanavipas S, Vallibhakara O, Sobhonslidsuk A, Phongkitkarun S, Vallibhakara SA-O, Promson K, et al. Abdominal Obesity as a Predictive Factor of Nonalcoholic Fatty Liver Disease Assessed by Ultrasonography and Transient Elastography in Polycystic Ovary Syndrome and Healthy Women. Biomed Res Int [Internet]. 2019 Aug 4 [cited 2020 Apr 11];2019. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699391/
[69] Sobhonslidsuk A, Pulsombat A, Kaewdoung P, Petraksa S. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes. Asian Pac J Cancer Prev. 2015;16(5):1789–94.
[70] Pongpit J, Porntharukchareon S, Kaewduang P, Promson K, Stitchantrakul W, Petraksa S, et al. Liver Stiffness Measurement in Psoriasis: Do Metabolic or Disease Factors Play the Important Role? Biomed Res Int. 2016;2016:7963972.
[71] Teeratorn N, Piyachaturawat P, Thanapirom K, Chaiteerakij R, Sonsiri K, Komolmit P, et al. Screening for non-alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter-transient elastography. JGH Open. 2020;4(2):245–50.
[72] Summart U, Thinkhamrop B, Chamadol N, Khuntikeo N, Songthamwat M, Kim CS. Gender differences in the prevalence of nonalcoholic fatty liver disease in the Northeast of Thailand: A population-based cross-sectional study. F1000Res [Internet]. 2017 Oct 20 [cited 2020 Apr 11];6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645706/
[73] Fan J-G, Kim S-U, Wong VW-S. New trends on obesity and NAFLD in Asia. Journal of Hepatology. 2017 Oct 1;67(4):862–73.
[74] Younossi ZM, Stepanova M, Negro F, Hallaji S, Younossi Y, Lam B, et al. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore). 2012 Nov;91(6):319–27.
[75] Wei JL, Leung JC-F, Loong TC-W, Wong GL-H, Yeung DK-W, Chan RS-M, et al. Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy. Am J Gastroenterol. 2015 Sep;110(9):1306–14; quiz 1315.
[76] Dey PK, Sutradhar SR, Barman TK, Khan NA, Hasan I, Haque MF, et al. Risk factors of non-alcoholic fatty liver disease. Mymensingh Med J. 2013 Oct;22(4):649–54.
[77] Singh DK, Sakhuja P, Malhotra V, Gondal R, Sarin SK. Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis. Dig Dis Sci. 2008 Jul;53(7):1967–76.
[78] Choudhary NS, Duseja A, Kalra N, Das A, Dhiman RK, Chawla YK. Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD). Ann Hepatol. 2012 Aug;11(4):478–86.
[79] Duseja A, Chalasani N. Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD). Hepatol Int. 2013 Dec;7 Suppl 2:755–64.
[80] Bhat G, Baba CS, Pandey A, Kumari N, Choudhuri G. Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease. Trop Gastroenterol. 2013 Mar;34(1):18–24.
[81] Niriella MA, Kasturiratne A, Pathmeswaran A, De Silva ST, Perera KR, Subasinghe SKCE, et al. Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri Lanka. Hepatol Int. 2019 May;13(3):314–22.
[82] Kumar R, Rastogi A, Sharma MK, Bhatia V, Garg H, Bihari C, et al. Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease? Indian J Endocrinol Metab. 2013;17(4):665–71.
[83] Alam S, Gupta UD, Alam M, Kabir J, Chowdhury ZR, Alam AKMK. Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh. Indian J Gastroenterol. 2014 Sep 1;33(5):452–7.